StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UBS Upgrades ResMed (RMD) to Buy
October 25, 2013 8:59 AM
UBS upgraded ResMed (NYSE: RMD) from Neutral to Buy.
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Upgrades
Next Articles
Deutsche Bank Downgrades ResMed (RMD) to Hold
October 25, 2013 8:55 AM
ResMed, Inc. (RMD) Misses Q1 EPS by 2c
October 24, 2013 4:43 PM